Viewing Study NCT00623103


Ignite Creation Date: 2025-12-24 @ 7:36 PM
Ignite Modification Date: 2026-01-04 @ 9:25 AM
Study NCT ID: NCT00623103
Status: COMPLETED
Last Update Posted: 2011-11-28
First Post: 2008-02-14
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD)
Sponsor: Novartis
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2008-01
Start Date Type: None
Primary Completion Date: 2010-11
Primary Completion Date Type: ACTUAL
Completion Date: None
Completion Date Type: None
First Submit Date: 2008-02-14
First Submit QC Date: None
Study First Post Date: 2008-02-25
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2011-10-19
Results First Submit QC Date: None
Results First Post Date: 2011-11-28
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2011-10-19
Last Update Post Date: 2011-11-28
Last Update Post Date Type: ESTIMATED